GAVISCON - 0135-0094-41 - (aluminum hydroxide and magnesium carbonate)

Alphabetical Index


Drug Information of GAVISCON

Product NDC: 0135-0094
Proprietary Name: GAVISCON
Non Proprietary Name: aluminum hydroxide and magnesium carbonate
Active Ingredient(s): 95; 358    mg/15mL; mg/15mL & nbsp;   aluminum hydroxide and magnesium carbonate
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of GAVISCON

Product NDC: 0135-0094
Labeler Name: GlaxoSmithKline Consumer Healthcare LP
Product Type: HUMAN OTC DRUG
FDA Application Number: part331
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20110114

Package Information of GAVISCON

Package NDC: 0135-0094-41
Package Description: 355 mL in 1 BOTTLE (0135-0094-41)

NDC Information of GAVISCON

NDC Code 0135-0094-41
Proprietary Name GAVISCON
Package Description 355 mL in 1 BOTTLE (0135-0094-41)
Product NDC 0135-0094
Product Type Name HUMAN OTC DRUG
Non Proprietary Name aluminum hydroxide and magnesium carbonate
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20110114
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name GlaxoSmithKline Consumer Healthcare LP
Substance Name ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE
Strength Number 95; 358
Strength Unit mg/15mL; mg/15mL
Pharmaceutical Classes

Complete Information of GAVISCON


General Information